DSCSA Serialization Requirements for Pharmaceutical Distributors
DSCSA serialization requires a unique product identifier on every drug package. Learn who must comply and the small-dispenser deadline of November 27, 2027.
What Is DSCSA Serialization?
The Drug Supply Chain Security Act (DSCSA) requires that every saleable unit of prescription medication carry a standardized product identifier. This identifier is encoded in both human-readable text and a 2D data matrix barcode, and it contains four elements:
- National Drug Code (NDC) — the 10-digit FDA-assigned product identifier
- Serial Number — a unique number assigned to each individual package by the manufacturer
- Lot Number — the production batch identifier
- Expiration Date — the date after which the product should not be dispensed
Together, these four elements form what FDA calls the "product identifier." Without all four, a package cannot be verified as authentic in the federal track-and-trace system.
DSCSA Enforcement Timeline
FDA phased in full enforcement of enhanced drug distribution security requirements across trading-partner types:
- November 27, 2023 — statutory deadline for all enhanced electronic, interoperable, package-level requirements; FDA established a one-year stabilization period
- November 27, 2024 — end of stabilization period; FDA issued phased exemptions in October 2024
- May 27, 2025 — manufacturers and repackagers became fully subject to all requirements
- August 27, 2025 — wholesale distributors became fully subject to all requirements
- November 27, 2025 — dispensers with 26 or more full-time pharmacy employees became fully subject
- November 27, 2027 — extended deadline: dispensers with 25 or fewer full-time pharmacy employees (small dispensers) must comply (FDA extended the original Nov 27, 2026 deadline by one year on August 7, 2026)
If your pharmacy has 25 or fewer full-time employees, November 27, 2027 is the current small-dispenser date for EPCIS interoperability. The exemption is automatic for eligible small dispensers — no FDA filing required. However, buying from authorized trading partners and maintaining suspect/illegitimate product procedures remain important throughout the exemption period. Verify current requirements against FDA guidance.
Who Must Comply?
Serialization requirements apply to all trading partners in the pharmaceutical supply chain, including:
- Manufacturers — must serialize product and encode it in the 2D barcode
- Repackagers — must serialize any product they repackage
- Wholesale distributors — must verify serialization before accepting or transferring product
- Pharmacies and dispensers — must accept only serialized product and be able to quarantine suspect product on request
Even if you only dispense product (and never redistribute it), you must be able to verify product identifiers and respond to verification requests from trading partners.
What Happens If You Receive Non-Serialized Product?
Pharmacies and distributors should refuse any prescription drug package that does not carry a compliant product identifier. Accepting non-serialized product exposes you to:
- FDA enforcement under DSCSA Section 582
- State board of pharmacy disciplinary action
- Potential criminal referral if the product is later found to be counterfeit or diverted
Premier Pharma provides a wholesale account and workflow tools for eligible businesses. Product documentation and current DSCSA requirements should be confirmed for the applicable product and order.
Verification Requirements
Trading partners must be able to electronically verify product identifiers against the manufacturer's database. This interoperability requirement means:
- Your pharmacy software or inventory system must be capable of submitting verification requests
- You must investigate and quarantine any product that fails verification
- Records of verification activities must be retained for 6 years
How Premier Pharma Helps
Licensed buyers can review available product documentation and ScriptTrack workflow support after account verification. Confirm the records and verification steps your business needs before ordering.
Continue your DSCSA review
Frequently Asked Questions
Is my pharmacy required to verify serialization on incoming shipments?
Yes — and when depends on your pharmacy's size. Dispensers with 26 or more full-time pharmacy employees became subject to full DSCSA enhanced requirements on November 27, 2025. Small dispensers with 25 or fewer full-time pharmacy employees received a one-year extension: they must comply by November 27, 2027. After that date, all dispensers must accept only serialized product with valid product identifiers and be able to quarantine and investigate suspect product.
What is a 2D data matrix barcode and how do I read it?
A 2D data matrix barcode is the square barcode printed on every drug package. It encodes the NDC, serial number, lot number, and expiration date in a machine-readable format. Any barcode scanner or smartphone camera with the right app can read it. Premier Pharma can help you integrate this into your receiving workflow.
What should I do if I receive product without a product identifier?
You should refuse the shipment or quarantine the product immediately. Contact your distributor to obtain compliant product. You may also need to report the issue to the FDA and your state board of pharmacy. Premier Pharma ships only compliant, serialized product.
Disclaimer: This guide is for informational purposes only and does not constitute legal or regulatory advice. DSCSA requirements are complex and evolving. Consult your legal counsel or compliance advisor for guidance specific to your situation. For official requirements, refer to the FDA's DSCSA guidance documents at fda.gov.